• Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Long‑term safety study of S68587 (allogeneic CD19 CAR T‑cells with TRAC and CD52 disruption) in patients with advanced lymphoid leukemia

    Not yet recruiting

    3 1 1
    Investigated diseases:
    France

  • Phase 1/2 Study of VS-7375 with Drug Combination in Patients with Advanced KRAS G12D‑Mutated Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain

  • Accelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Cognitive effects of a three‑month methylphenidate course in Parkinson’s disease patients with mild cognitive impairment

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Efficacy of sufentanil versus fentanyl for postoperative pain in patients undergoing urgent laparoscopic cholecystectomy

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • Semaglutide for weight management in adults with obesity and binge‑eating: a study to identify who benefits

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Rituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

    Not yet recruiting

    2 1
    The Netherlands Poland

  • Phase Ib/II Study of Bexmarilimab Plus Doxorubicin in Adults with Metastatic Soft Tissue Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

powered by